Storage: All of our manufacturing partners produce peptides using the Lyophilization (Freeze Drying) process, ensuring products maintain stability for shipping and storage for 12+ months
In Phase 1 and 2a clinical trials, once-daily subcutaneous injections of RG7697 (0.252.5 mg) for 14 days in 56 patients with T2DM and 1.8 mg of RG7697 for 12 weeks in patients with T2DM who were poorly responsive to metformin reduced body weight and improved glycemic control
Obesity Research: Pre-clinical obesity studies have reported substantial effects on body weight, food intake, and fat mass in animal models, with research attributing the breadth and magnitude of these effects to the combined tri-receptor mechanism particularly the additive contribution of glucagon receptor-driven energy expenditure alongside dual incretin activity
[DOI] [PMC free article] [PubMed] [Google Scholar] 190.Kim M., Seol J., Sato T., Fukamizu Y., Sakurai T., Okura T
Mandatory lab work can delay the start of treatment
The mechanism of action is very imbalanced, since while it has a comparable GIP receptor binding affinity to native GIP, the affinity to the native GLP-1 receptor is five times lower [20, 21]
